tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Energy

tanzania times : Latest News and In-depth Analysis
HomeEnergy
Energy

Mar 5, 2025

Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma

SAN FRANCISCO andSUZHOU,China,March 3,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures,and commercializes high-qua

All News

Energy

New era of TA: Cielo launches Agentic AI

MILWAUKEE,March 5,2025--Cielo,the world\'s leading Talent Acquisition Partner,today releases Agentic AI for TA. These agents are proactive teammates that elevate and enable their human counterparts t

Mar 6, 2025

Full Truck Alliance Co. Ltd. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

GUIYANG,China,March 5,2025-- Full Truck Alliance Co. Ltd. ("FTA" or the"Company") (NYSE: YMM),a leading digital freight platform,today announced its unaudited financial results for

Mar 6, 2025

Energy

2025 Call for Code Engages Developers to Build AI Solutions that Address Social and Humanitarian Issues

In its eighth year,Call for Code presents a series of SDG-focused hackathons throughout the year,kicking off with a competition to build AI agents

Mar 6, 2025

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024

Mar 6, 2025

Energy

Massimo Motor Strengthens Strategic Partnerships at Rural King Vendor Summit, Tractor Supply Company & PetSense ASM and Partner Trade Show

Massimo\'s participation in these vendor summits is not only about showcasing its lineup of UTVs,ATVs and outdoor equipment but also about listening and learning.

Mar 6, 2025

Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

HONG KONG,March 6,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical tria

Mar 6, 2025

1 ... 8 9 10 11 12 13 14 ... 70